S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q4 2021

BVF Partners

Period: Q4 2021 Β· Filed: 2022-02-14
View on SEC EDGAR β†—
AUM
$2.76B
Total portfolio value
Positions
83
Reported securities
Top Holding
GHRS
7.8% $216.4M
QoQ Changes
+8 / -3
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHRSGH RESEARCH PLC$216.4M7.85%$23.33$27.01+15.8%
7.8%
KYMRKYMERA THERAPEUTICS INC$201.9M7.33%$63.49$113.51+78.8%
7.3%
RCUSARCUS BIOSCIENCES INC$137.5M4.99%$40.47$30.33-25.1%
5.0%
MRUSMERUS N V$131.5M4.77%β€”β€”
4.8%
PTGXPROTAGONIST THERAPEUTICS INC$124.9M4.53%$34.20$131.62+284.9%
4.5%
XENEXENON PHARMACEUTICALS INC$102.8M3.73%$31.24$60.96+95.1%
3.7%
RPTXREPARE THERAPEUTICS INC$102.5M3.72%β€”β€”
3.7%
RLAYRELAY THERAPEUTICS INC$96.1M3.49%$30.71$18.65-39.3%
3.5%
CRNXCRINETICS PHARMACEUTICALS IN$85.3M3.10%$28.41$42.23+48.6%
3.1%
CGEMCULLINAN ONCOLOGY INC$82.8M3.01%$15.43$17.63+14.3%
3.0%
ARGXARGENX SE$75.7M2.75%$350.19$939.68+168.3%
2.8%
XOMAXOMA CORP DEL$73.6M2.67%$20.85$43.00+106.2%
2.7%
OLMAOLEMA PHARMACEUTICALS INC$69.4M2.52%$9.36$12.64+35.0%
2.5%
LKFTGALAPAGOS NV$63.8M2.31%$55.13$30.39-44.9%
2.3%
LXRXLEXICON PHARMACEUTICALS INC$56.6M2.05%$3.94$2.32-41.1%
2.0%
AMRNXXXXAMARIN CORP PLC$55.5M2.01%β€”β€”
2.0%
EQRXEQRX INC$53.6M1.95%β€”β€”
1.9%
SNDXSYNDAX PHARMACEUTICALS INC$46.0M1.67%$21.89$21.82-0.3%
1.7%
RVMDREVOLUTION MEDICINES INC$45.6M1.65%$25.17$189.24+651.9%
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$44.0M1.60%$21.94$13.00-40.8%
1.6%
EPIXESSA PHARMA INC$40.5M1.47%β€”β€”
1.5%
RAINRAIN THERAPEUTICS INC$38.1M1.38%β€”$1.97
1.4%
VRDNVIRIDIAN THERAPEUTICS INC$37.2M1.35%$19.77$19.40-1.9%
1.4%
RLMDRELMADA THERAPEUTICS INC$37.1M1.35%$22.53$6.28-72.1%
1.4%
VSTMXXXXVERASTEM INC$35.0M1.27%β€”β€”
1.3%
ACIUAC IMMUNE SA$35.0M1.27%$4.95$2.51-49.3%
1.3%
KDNYCHINOOK THERAPEUTICS INC$29.4M1.07%β€”β€”
1.1%
KURAKURA ONCOLOGY INC$28.9M1.05%$14.00$11.10-20.7%
1.1%
TYRATYRA BIOSCIENCES INC$26.4M0.96%$14.07$30.62+117.6%
1.0%
SPROSPERO THERAPEUTICS INC$25.4M0.92%$16.01$2.20-86.3%
0.9%

Quarter-on-Quarter Activity

Q4 2021 vs. Q3 2021

New Positions (8)

TickerIssuerNotionalSince Filing
MRUSMERUS N V$131.5M
EQRXEQRX INC$53.6M
RLMDRELMADA THERAPEUTICS INC$37.1M-72.1%
KDNYCHINOOK THERAPEUTICS INC$29.4M
CTMXCYTOMX THERAPEUTICS INC$25.1M
PYXSPYXIS ONCOLOGY INC$19.6M
CNCECONCERT PHARMACEUTICALS INC$7.1M
CNTACENTESSA PHARMACEUTICALS PLC$5.1M

Exited Positions (3)

TickerIssuerNotional
MERUS N V$111.3M
GRTSQGRITSTONE BIO INC$16.5M
ANABANAPTYSBIO INC$9.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CGEMCULLINAN ONCOLOGY INC$66.3M+630.4%+14.3%
RNACSELECTA BIOSCIENCES INC$4.3M+439.0%
CRNXCRINETICS PHARMACEUTICALS IN$65.3M+214.9%+48.6%
VRDNVIRIDIAN THERAPEUTICS INC$23.9M+133.7%-1.9%
XENEXENON PHARMACEUTICALS INC$78.8M+109.3%+95.1%
RLAYRELAY THERAPEUTICS INC$31.5M+52.8%-39.3%
AMRNXXXXAMARIN CORP PLC$-2.7M+44.3%
CDTXXXXXCIDARA THERAPEUTICS INC$-2.0M+43.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ARGXARGENX SE$-34.9M-41.0%+168.3%
RVMDREVOLUTION MEDICINES INC$-22.8M-27.1%+651.9%
INFIQINFINITY PHARMACEUTICALS INC$-14.4M-24.2%
WHWKAADI BIOSCIENCES INC$-12.0M-21.6%
SNDXSYNDAX PHARMACEUTICALS INC$-1.6M-15.6%-0.3%
SPROSPERO THERAPEUTICS INC$-7.9M-12.4%-86.3%
PTGXPROTAGONIST THERAPEUTICS INC$55.8M-6.4%+284.9%
IKNAIKENA ONCOLOGY INC$-0.6M-1.8%
← Back to Hedge Funds